The overall goal of the proposed research is to elucidate the role of extracellular and intracellular pH in determining the toxicity of chemotherapeutic drugs to cancer cells in vitro and in vivo. Results from our laboratory and from others indicate that intracellular and extracellular pH may play an important role in determining cellular response to the antitumor drug, mitomycin C, in vitro. Therefore, the effects of altering the intracellular and extracellular pH microenvironment on the cytotoxicity and molecular damage produced by mitomycin C, chlorozotocin, and 1,3-bis-(2-chloroethyl)-1-nitrosourea will be studied in EMT6 mouse mammary carcinoma cells in vitro. Intracellular pH will be measured using flow cytometry to detect a pH sensitive fluorescent dye. Cytotoxicity will be determined using colony formation assays and molecular damage will be assessed using alkaline elution methods to detect DNA single strand breaks, DNA-DNA crosslinking, and DNA-protein crosslinking. BALB/c KaRw mice bearing EMT6 tumors will be used to assess tumor pH in vivo and to determine the effects of pH on antitumor drug efficacy in vivo. The effects of regional variations in tumor pH on tumor cell sensitivity to drug will be determined using colony formation assays and alkaline elution measurements of drug- induced DNA damage. Because cellular regulation of pH is controlled by two ion exchangers, a Na+/H+ exchanger and a C1- /HCO3- exchanger, the drugs which inhibit these exchangers will be used to manipulate pH and alter drug toxicity. The knowledge obtained from these studies may enable the design of therapeutic regimens which will be effective against tumor cells situated in low pH environments.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA041239-01A2
Application #
3181518
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1987-07-01
Project End
1990-12-31
Budget Start
1987-07-01
Budget End
1988-12-31
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
George Washington University
Department
Type
Schools of Medicine
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20052
Lin, Z P; Boller, Y C; Amer, S M et al. (1998) Prevention of brefeldin A-induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-kappaB activation in drug resistance. Cancer Res 58:3059-65
Laurencot, C M; Kennedy, K A (1995) Influence of pH on the cytotoxicity of cisplatin in EMT6 mouse mammary tumor cells. Oncol Res 7:371-9
Laurencot, C M; Andrews, P A; Kennedy, K A (1995) Inhibitors of intracellular pH regulation induce cisplatin resistance in EMT6 mouse mammary tumor cells. Oncol Res 7:363-9
Rockwell, S; Hughes, C S; Keyes, S R et al. (1993) Porfiromycin as an adjunct to radiotherapy in young and old mice. Exp Gerontol 28:281-93
Rockwell, S; Sartorelli, A C; Tomasz, M et al. (1993) Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastasis Rev 12:165-76
Keyes, S R; Rockwell, S; Kennedy, K A et al. (1991) Distribution of porfiromycin in EMT6 solid tumors and normal tissues of BALB/c mice. J Natl Cancer Inst 83:632-7
Rockwell, S; Hughes, C S; Kennedy, K A (1991) Effect of host age on microenvironmental heterogeneity and efficacy of combined modality therapy in solid tumors. Int J Radiat Oncol Biol Phys 20:259-63
Sostman, H D; Charles, H C; Rockwell, S et al. (1990) Soft-tissue sarcomas: detection of metabolic heterogeneity with P-31 MR spectroscopy. Radiology 176:837-43
Sostman, D; Rockwell, S; Smith, G J et al. (1988) Magnetic resonance, pathology and physiology of the BA1112 rhabdomyosarcoma in vivo. Invest Radiol 23:277-88